Dilemmas in harm minimization
|
|
- Evelyn Wilkerson
- 5 years ago
- Views:
Transcription
1 FOR DEBATE doi: /j x Dilemmas in harm minimization Don Weatherburn NSW Bureau of Crime Statistics and Research, Sydney, Australia ABSTRACT This paper discusses the dilemmas inherent in pursuing a philosophy of (drug) harm minimization. The dilemmas arise (i) because all drug control policies produce harms as well as benefits; (ii) because many of these harms and benefits cannot be measured; and (iii) because even when they can be measured, judgements about what harms matter the most are irreducibly political. The paper concludes by proposing that the interests of drug policy might be better served if we abandoned the idea of an overarching goal in favour of a set of goals dealing with specific identifiable problems. Keywords Drug policy goal, drug user, harm minimization, harm reduction, methadone, supply control. Correspondence to: Don Weatherburn, NSW Bureau of Crime Statistics and Research, GPO Box 6, Sydney, Australia. don_j_weatherburn@agd.nsw.gov.au Submitted 18 March 2008; initial review completed 5 June 2008; final version accepted 26 June 2008 INTRODUCTION It has often been said that the goal of drug policy should be to reduce or minimize the harm associated with drug use rather than reduce or minimize drug use itself. At first blush, the injunction seems sensible enough. All societies use drugs of one sort or another and the eradication of drug use would seem well nigh impossible. Moreover, some of the measures we take to reduce drug use (e.g. imprisoning people for minor drug offences) seem to do more harm than good. There are many ways in which we can reduce drug-related harm without reducing drug use. If the main reason for seeking to reduce drug use is to reduce drug-related harm, why not make the latter the goal of policy and treat the former as one means among many directed toward that end? If we probe a little deeper, however, the beguiling simplicity of harm minimization begins to disappear. Whose harm should we try to minimize and how do we compare qualitatively different types of harm? Is it possible to compare the harm done by injecting drug users when they discard their equipment in a public park, with the harm done to injecting drug users when they are unfairly harassed by police; when fear of arrest prompts them to inject too quickly; or when in a bid to avoid detection, they share injecting equipment? When reducing the harm suffered by users increases the harm suffered by everyone else, whose interests should prevail? What principle should we adopt to make such decisions? These questions are critical to the achievement of harm minimization but have attracted little scholarly attention. The purpose of this paper is to examine these questions and their implications. The next section deals briefly with definitional issues. The three sections that follow discuss the dilemmas associated with supply, demand and harm reduction. The penultimate section discusses the problems with harm minimization as a policy goal. The final section puts forward an alternative to harm minimization. DEFINING HARM REDUCTION/MINIMIZATION There is little agreement on the meaning of the terms harm reduction and harm minimization [1 3]. This is not the place for a general discussion of definitional issues, but clarity of terms is essential if the arguments presented below are to be understood clearly. Following the general approach adopted by Wodak & Saunders [4], I draw a distinction between harm reducing, harm reduction and harm minimization. The first term I use to describe any intervention, programme or policy intended to reduce the harm associated with drug use, including measures designed to reduce drug use. The second term I reserve for measures that are designed to reduce the harms associated with drug use by means other than reducing drug use (e.g. needle and syringe exchange programmes). The third term ( harm
2 336 Don Weatherburn minimization ) I use to refer to the view that the overall goal of drug policy should be to minimize drug-related harm, in all its manifold forms. DILEMMAS IN SUPPLY CONTROL Harm minimization is pursued generally through three broad strategies: supply reduction, demand reduction and harm reduction [5]. There is little doubt about the harm-reducing potential of supply control. The risks and costs associated with drug trafficking make illegal drugs much more expensive than they would otherwise be [6]. There is now a substantial body of evidence [7] that demand for drugs such as heroin and cocaine is pricesensitive. Thus, even if supply-side drug law enforcement does nothing more than limit the extent to which illegal drug prices fall, it limits the scale of illicit drug use and some of its associated harm. The harm-reducing character of supply control policy is most vividly apparent in Australia, where a huge jump in Australian heroin prices produced dramatic falls in heroin-related crime, fatal heroin overdoses and notifications of hepatitis C [8]. Less spectacular but no less potent evidence of the harm reducing potential of supply control policy can be found in the inverse relationship between rates of entry into emergency departments in the United States and trends in the price of heroin and cocaine [9]. Supply control policy, however, also generates a great deal of harm. The harms associated with supply reduction or the law enforcement practices associated with it include loss of civil liberty [10], increased risk of overdose and disease [11] and greatly increased rates of imprisonment [12]. The risk of imprisonment may assist in keeping retail drug prices high, but imprisonment reduces substantially an individual s future legitimate employment and earnings prospects [13]. Evidence has emerged recently that it may also increase significantly the risk of further involvement in crime [14]. There are other problems as well. The risk we take when supply side drug law enforcement pushes up the price of one illegal drug is that drug users will switch to another. There is some evidence that efforts to restrict the supply of heroin have prompted some street-based heroin users to switch to methamphetamine and cocaine [11]. These are drugs that, if used frequently over a prolonged period, can produce aggression, hostility and paranoia [15]. DILEMMAS IN DEMAND REDUCTION Recognition of the costs associated with supply control policy has prompted many to argue that we should put more emphasis upon demand reduction. One of the best ways to reduce the demand for illicit drugs is to provide drug users with treatment. Methadone maintenance treatment, for example, has been shown in a number of randomized controlled trials to reduce heroin consumption and heroin-related crime [16]. Despite its benign appearance, however, demand reduction strategies can also generate harm. Few injecting drug users are prompted to stop using illegal drugs because of their adverse pharmacological effects. The most common reasons given by injecting drug users for entering treatment are trouble with the police, the cost of illegal drugs and the life-style associated with illicit drug dependence that is, the endless scamming, theft, violence, hassles with police and ever-present risk of imprisonment [17,18]. Policy makers may view these conditions as an inducement to seek treatment but drug users view them as significant harms, as indeed they are. If the effectiveness of treatment in reducing aggregate drug consumption depends upon the enforcement of sanctions associated with drug use, it is difficult to get the best out of treatment without inflicting a certain amount of harm. Treatment is also capable of inflicting harm in a more direct way. Because it reduces demand relative to supply, the provision of treatment may drive down drug prices in the illegal market, enticing more people into drug use. People on methadone maintenance treatment sometimes sell their methadone to others. Some have given methadone to their infant children, with predictable and tragic results. In some circumstances treatment may even encourage illicit drug use. Best and colleagues [19], at the National Addiction Centre in London, found that polydrug users in methadone treatment were spending much more on crack cocaine than those who were not in treatment. This suggests that some heroin users may take refuge in methadone knowing that it will release funds to buy other illegal drugs. DILEMMAS IN HARM REDUCTION This brings us to harm reduction. There is no doubt about the benefits that flow from some harm reduction initiatives. The needle and syringe programme, for example, limited the spread of human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS). Do harm reduction initiatives ever cause any harm? This is a difficult question to answer, because the impact of harm reduction measures on illicit drug consumption is not examined very often. The best-evaluated example of a harm reduction measure is the removal of penal sanctions from cannabis use (de-penalization). The effects of de-penalization remain the subject of considerable debate [12,20 22]; but even if we knew that although removing the penal sanctions associated with cannabis use reduced the harm associated with the drug, it would not follow that we can
3 Dilemmas in harm minimization 337 pursue a comprehensive harm reduction programme without any risk of stimulating drug use. Consider some of the things policy makers could do if they were really serious about reducing drug-related harm. They could provide all drug users with a service that allows them to test the purity and composition of the drugs they buy on the black market. To mitigate the risks associated with rapid injection they could adopt a policy of not arresting people caught in the act of injecting illicit drugs. To mitigate the risks associated with intranasal or oral storage of illegal drugs they establish a protocol limiting the power police have to search the mouth or nose of someone they suspect to be carrying drugs in those cavities. To avoid compromising the education of schoolchildren they could adopt a policy of not expelling or suspending students caught using illegal drugs. They could establish a medically supervised injection centre in every neighbourhood with substantial numbers of injecting drug users or remove criminal sanctions altogether from personal drug use or possession (decriminalization). These sorts of initiatives are rarely, if ever, pursued because policy makers (and the general public) are fearful that they would send the wrong message ; that is, increase the rate of initiation into drug use and/or consumption among existing users. It is customary in some circles to dismiss this fear but, as Hall [23] points out, we do not dismiss it when tobacco companies attempt to reduce the harm associated with smoking by creating a non-smoked form of tobacco. The point is that the harms associated with certain practices are sometimes the most important brake on their adoption. Musto [24] has argued that one reason for the cyclical nature of drug epidemics is that the rate of initiation into drug use begins to slow as the harms associated with heavy use become increasingly apparent. The model of the US cocaine market developed by Caulkins et al. [25], which is based on this idea, gives a good account of the time course of the US cocaine epidemic. If his model is correct, there is an unavoidable trade-off between minimizing the harm associated with cocaine and minimizing the number of new recruits to the drug. If this is true of cocaine it may well be true of other illegal drugs. PROBLEMS WITH HARM MINIMIZATION AS A GOAL So far all we have done is show that supply reduction, demand reduction and harm reduction all result in harms as well as benefits. It could be argued that, while this complicates the process of minimizing harm, it does not render it impossible. All one has to do is measure the harms associated with various initiatives, weigh them in terms of their relative importance and then select whatever combination of initiatives best minimizes the harm associated with drug use. The UK Home Office is pursuing a project of this kind [26], and Ball [27] has also spoken recently of the possibility of model (harm reduction) packages. The problem is that we have no practical means of measuring many drug-related harms. We know from ethnographic research, for example, that street-level drug law enforcement sometimes encourages drug users to inject rapidly or share needles to avoid being caught [28], but we have no practical means of quantifying the scale of this problem or the harm that it causes. The same applies to the loss of civil liberty that results from an expansion in police powers of search and seizure, the loss of privacy that results from an expansion of police powers of surveillance, the loss of public amenity associated with public drug use or the scale of the black market in methadone created by offering take-away doses. Researchers might be able to make informed guesses about the dimensions of some of these problems but, as Hawks & Lenton [29] point out, in most instances drug policy decisions have to be made without any real capacity to measure the harms they may produce. There is another even more profound problem. Even if we could measure the harms and benefits associated with alternative drug policies, there is no common scale against which they can be compared. To see this, consider two hypothetical policies. One policy cuts public drug dealing by 20%, but encourages needle sharing and results in many innocent teenagers being stopped, searched and questioned by police. The other policy reduces needle sharing and minimizes the number of innocent teenagers stopped, searched and questioned by police but, as a consequence, produces a higher level of drug trafficking and drug-related loitering in and around areas that have methadone clinics. Which policy should we adopt? The principle of harm minimization is no help to us here. No amount of research or calculation can tell us whether the benefits associated with heroin supply reduction (in terms of reduced deaths, reduced disease and reduced crime) are worth the costs (in terms of increased uptake of psychostimulants and their sequelae). Nor can any research tell us whether the loss of civil liberty associated with an increase in police street-level drug law enforcement powers is worth the gain in public amenity. The harms associated with drug use (and our control strategies) are incommensurable. Even a complete understanding of the costs and consequences of various drug policy alternatives would not tell us what policy best minimizes drug-related harm. This is because decisions about what policy to adopt invariably come down to political (value) judgements about what risks, harms and benefits (i.e. outcomes) matter the most. This is not a job for researchers; it is a job for politicians and the public at large.
4 338 Don Weatherburn It might be objected that we are taking harm minimization far too literally; that a commitment to harm minimization is not a commitment to minimizing some measured quantity in the strict mathematical sense, but rather a commitment to putting the focus of drug policy on the harm caused by drug use rather than on drug use per se. There are two problems with this. The first is that it is unhelpful to say that the goal of drug policy is harm minimization if there is any room for ambiguity over precisely what this means. Some may be happy to use the terms in question in a way that is inclusive of use reduction. However, as Hall recently pointed out [23], the term harm reduction is an anathema to North American drug warriors, who see it as a Trojan Horse for drug legalization. He has expressed doubts about the worth of a term that means so many different things to different people and that provokes such strongly opposed views. His doubts seem well founded. The second and larger problem with the idea that the goal of drug policy should be to minimize the harm associated with drugs is that it obscures the central dilemma in drug policy in an environment where reducing one set of harms usually increases others, which harms should we reduce? There is no meaningful sense in which we can minimize all the harms associated with a particular drug. All we can ever do is reduce some harms while trying, sometimes forlornly, not to generate or exacerbate others. Instead of forcing us to confront difficult questions about whether (for instance) enforcement practices designed to improve public amenity in drug-dealing hotspots are worth the cost in terms of unsafe injection practices, or whether strategies designed to raise the (monetary and non-monetary) cost of drug use are worth the cost in terms of lost civil liberty and higher rates of imprisonment, invocations to minimize harm simply encourage us to ignore certain problems in favour of others. BEYOND HARM MINIMIZATION Hall [23] has recommended that we abandon the term harm reduction and speak instead about public health measures. This would be an improvement on the current situation, but it does not go far enough. Some of the harms associated with drug use are not, in any meaningful sense, public health harms (e.g. loss of public amenity, poor school performance, theft). Rather than adopt any general guiding principle, it would make more sense to try to reach agreement on the specific drug problems we want to reduce and make their reduction the goal of illicit drug policy. Thus, instead of saying we want to minimize the harm associated with injecting drug use, we might (for example) simply say that we want only to minimize the number of new recruits to injecting drug use, encourage more injecting drug users into treatment, reduce the crime committed by injecting drug users and improve public amenity in areas where injecting drug use is prevalent. The advantages of proceeding in this way are twofold. First, the requirement to list the specific problems we want to address will stimulate a more open and frank debate about what problems matter the most. Secondly, if we engage in open debate about which problems matter the most, it should become much easier to identify the points where compromises must be made in the achievement of drug policy goals. Declarations of interest None. Acknowledgements My thanks to Professor Richard Mattick, Director of the National Drug and Alcohol Research Centre for his helpful comments on an early draft of this paper. References 1. Hawks D., Lenton S. Harm minimisation: a basis for decision making in drug policy? Risk Decision Policy 1998; 3: Lenton S., Single E. The definition of harm reduction. Drug Alcohol Rev 1998; 17: Ritter A., Cameron J. A Systematic Review of Harm Reduction. Drug Policy Modelling Project Monograph no. 6. Melbourne: Turning Point; Wodak A., Saunders B. Harm reduction means what I choose it to mean. Drug Alcohol Rev 1995; 14: Ministerial Council on Drug Strategy. The National Drug Strategy: Australia s Integrated Framework, Canberra: Commonwealth of Australia; Reuter P., Kleiman M. Risks and prices: an economic analysis of drug enforcement. In: Morris N., Tonry M., editors. Crime and Justice: An Annual Review of Research, vol. 7. Chicago: University of Chicago Press; 1986, p Manski C. F., Pepper J. V., Petrie C. V. Informing America s Drug Policy: What We Don t Know Keeps Hurting Us. Washington, DC: National Academy Press; 2001, p Degenhardt L., Reuter P., Collins L., Hall W. Evaluating explanations of the Australian heroin shortage. Addiction 2005; 100: Caulkins J. P. Drug prices and emergency department mentions for cocaine and heroin. Am J Public Health 2001; 91: Wisosky S. A Society of Suspects: The War on Drugs and Civil Liberties. Cato Policy Analysis Available at: (accessed 24 January 2008). 11. Maher L., Li J., Jalaludin B., Wand H., Jayasuriya R., Dixon D. et al. Impact of a reduction in heroin availability on patterns of drug use, risk behaviour and incidence of hepatitis C virus infection in injecting drug users in New South Wales, Australia. Drug Alcohol Depend 2007; 89:
5 Dilemmas in harm minimization MacCoun R. J., Reuter P. Drug War Heresies: Learning from Other Vices, Times and Places. Cambridge: Cambridge University Press; Fagan J., Freeman R. B. Crime and work. In: Tonry M., editor. Crime and Justice: A Review of Research; 25. Chicago: University of Chicago Press; 1999, p Vieraitis L. M., Kovandzic T. V. The criminogenic effects of imprisonment: evidence from state panel data. Criminology 2007; 6: van Beek I., Dwyer R., Malcolm A. Cocaine injecting: the sharp end of drug-related harm! Drug Alcohol Rev 2001; 20: Hall W. Methadone Maintenance Treatment as a Crime Control Measure. Crime and Justice Bulletin no. 29. Sydney: NSW Bureau of Crime Statistics and Research; Bammer G., Weekes S. Becoming an ex-user: would the controlled availability of heroin make a difference? Feasibility Research into the Controlled Availability of Opioids Stage 2. Working paper no. 4. Canberra: National Centre for Epidemiology and Population Health, The Australian National University; Weatherburn D., Lind B., Forsythe L. Street-level law enforcement and entry into methadone maintenance treatment. Addiction 2001; 96: Best D., Sidwell C., Gossop M., Harris J., Strang J. Crime and expenditure among poly-drug users seeking treatment. Br J Criminol 41: Donnelly N., Hall W., Christie P. The effects of partial decriminalisation of cannabis use in South Australia, Aust J Public Health 1998; 19: Weatherburn D., Jones C., Donnelly N. Prohibition and cannabis use in Australia: a survey of year olds. Aust NZ J Criminol 2003; 36: Hall W., Pacula R. L. Cannabis Use and Dependence. Cambridge: Cambridge University Press; Hall W. What s in a name. Addiction 2007; 102: Musto D. F. The American Disease: Origins of Narcotic Control. New York: Oxford University Press; Caulkins J. P., Behrens D. A., Knoll C., Tragler G., Zuber D. Markov chain modelling of initiation and demand: the case of the US cocaine epidemic. Health Care Manag Sci 2004; 7: MacDonald Z., Tinsley L., Collingwood J., Jamieson P., Pudney S. Measuring the Harm from Illegal Drugs Using the Drug Harm Index. Home Office Online Report 24/05. London: Home Office; Ball A. L. HIV, injecting drug use and harm reduction: a public health response. Addiction 2007; 102: Maher L., Dixon D., Lynskey M., Hall W. Running the Risks: Heroin, Health and Harm in South West Sydney. National Drug and Alcohol Research Centre Monograph no. 38. Sydney: University of New South Wales; Hawks D., Lenton S. Harm minimisation: a basis for decision making in drug policy? Risk Decision Policy 1998; 3:
Components of good drug policy
Components of good drug policy Dr Caitlin Hughes National Drug Summit 2 March 2015 Parliament House What would a good policy look like? No silver bullet or one recipe to solve the drug problem But there
More informationVictorian Aboriginal Legal Service Co-operative Ltd.
Victorian Aboriginal Legal Service Co-operative Ltd. Head Office: 6 Alexandra Parade, P.O. Box 218 Fitzroy, Victoria 3065 Phone: (03) 9419 3888 (24 Hrs) Fax: (03) 9419 6024 Toll Free: 1800 064 865 Submission
More informationWhat is harm reduction?
What is harm reduction? The International Harm Reduction Association (IHRA) defines harm reduction as the policies, programmes and practices that aim to reduce the harms associated with the use of psychoactive
More informationFrequently Asked Questions about Supervised Injecting Facilities 24 July 2014
Frequently Asked Questions about Supervised Injecting Facilities 24 July 2014 1 Q: What are Supervised Injecting Facilities? A: These are places where people who inject drugs can go to inject in relative
More informationDecriminalization of Personal Use of Psychoactive Substances
DRAFT POSITION STATEMENT Decriminalization of Personal Use of Psychoactive Substances The use of illegal psychoactive substances (IPS) in Canada persists despite ongoing efforts to limit their consumption.
More informationStatement by the Portuguese Deputy Minister for Health. Vienna, 8 March 2010
Statement by the Portuguese Deputy Minister for Health 53 nd Session of the Commission on Narcotic Drugs Vienna, 8 March 2010 Mr. Chairman, Distinguished Delegates, Ladies and Gentlemen, First, I would
More informationINTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D
INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D Secretariat for Multidimensional Security FIFTY-FIFTH REGULAR SESSION April 29 - May 1, 2014 Washington, D.C. OEA/Ser.L/XIV.2.55 CICAD/doc.2094/14
More informationA reduction in the availability of heroin in Australia
A reduction in the availability of heroin in Australia RICHARD P. MATTICK Professor of Drug and Alcohol Studies, School of Public Health and Community Medicine, University of New South Wales, and Director
More informationStatistical Bulletin. The methamphetamine market: police detainee perspectives. Trends in reported methamphetamine use. April 2018
Statistical Bulletin 06 ISSN 2206-7302 April 2018 Abstract The data in this report were collected as part of the Australian Institute of Criminology s Drug Use Monitoring in Australia (DUMA) program, which
More informationGreens NSW Drug Regulation and Harm Minimisation Policy
Greens NSW Drug Regulation and Harm Minimisation Policy Revised February 2015 Principles The NSW Greens believe: 1. Drug use has occurred throughout history and this is unlikely to change. Further, abuse
More informationReport Information from ProQuest
Report Information from ProQuest March 11 2014 12:40 11 March 2014 ProQuest Table of contents 1. Legalizing drugs has pros and cons:... 1 11 March 2014 ii ProQuest Document 1 of 1 Legalizing drugs has
More informationPOLICY AND GUIDANCE FOR MANAGERS ON STAFF SUBSTANCE MISUSE
POLICY AND GUIDANCE FOR MANAGERS ON STAFF SUBSTANCE MISUSE HEALTH & SAFETY UNIT AUTUMN 2012 CONTENTS 1 INTRODUCTION... ERROR! BOOKMARK NOT DEFINED. 2 AIM... ERROR! BOOKMARK NOT DEFINED. 3 APPLICATION...
More informationMarijuana Legalization 2016: Understanding the policy landscape and design considerations
Marijuana Legalization 2016: Understanding the policy landscape and design considerations Beau Kilmer, PhD Co-Director, RAND Drug Policy Research Center Senior Policy Researcher, RAND Corporation Professor,
More informationDecriminalization of Personal Use of Psychoactive Substances
Decriminalization of Personal Use of Psychoactive Substances 2018 Position Statement Canadian Association of Social Workers Author: Colleen Kennelly Canadian Association of Social Workers (CASW) - 2018
More informationThe Meaning of the November Ballot Initiative to Legalize Recreational Marijuana
The Meaning of the November Ballot Initiative to Legalize Recreational Marijuana On Tuesday, November 6, 2018, Michigan citizens will be asked whether they want to legalize recreational marijuana. Medical
More informationOUTCOMES OF TRAINING GENERAL PRACTITIONERS TO PRESCRIBE METHADONE
LIBBY HOTHAM, ANN M ROCHE, EMMA FITZGERALD OUTCOMES OF TRAINING GENERAL PRACTITIONERS TO PRESCRIBE METHADONE LIBBY HOTHAM, ANN M ROCHE, EMMA FITZGERALD Over the last decade, most jurisdictions throughout
More informationCrime, persistent offenders and drugs: breaking the circle A Cumberland Lodge Conference 6 8 th June 2003
Crime, persistent offenders and drugs: breaking the circle A Cumberland Lodge Conference 6 8 th June 2003 Bullet point summary Statistics 50 percent of 16 29 year olds have tried illicit drugs, however
More informationThe science of the mind: investigating mental health Treating addiction
The science of the mind: investigating mental health Treating addiction : is a Consultant Addiction Psychiatrist. She works in a drug and alcohol clinic which treats clients from an area of London with
More informationQuestions & Answers. What are the risks associated with consumption drug use?
Questions & Answers What are the risks associated with consumption drug use? Consumption drug use affects us all. Harms associated with consumption drug use are many and include the spread of infectious
More informationHarm Reduction. Supporting Evidence. What is Harm Reduction? Benefits of Harm Reduction
This document provides further for the (Moreland Hall) Harm Reduction Position Statement for the expansion of Harm Reduction services in Australia. What is Harm Reduction? Drug policies must be based on
More informationwho use drugs in order to assist them in reducing harm while in the cycle of addiction
August 16, 2016 } Accepts that illicit drug use is part of our world, and chooses to minimize its harmful effects rather than ignore or condemn them } Calls for the provision of services to people who
More informationTaking away the chaos The health needs of people who inject drugs in public places in Glasgow city centre
Taking away the chaos The health needs of people who inject drugs in public places in Glasgow city centre Plain-language summary The health needs of people who inject drugs in public places in Glasgow
More informationDrug Consumption Rooms: Legal barriers or just an excuse? Kirstie Douse Head of Legal Services Solicitor Advocate
Drug Consumption Rooms: Legal barriers or just an excuse? Kirstie Douse Head of Legal Services Solicitor Advocate What is a DCR? A facility that allows people to inject/smoke illicitly purchased drugs,
More informationWhat are they? Why do people take these drugs?
What are they? Legal or illegal highs, head shop or herbal highs are names given to psychoactive substances (drugs) that may be on sale in Ireland through shops that sell drug-related products (head shops,
More informationThe Pillars Approach: A Case Study
The Pillars Approach: A Case Study Dorothy J. Chaney, M.Ed. CADCA Trainer www.cadca.org Building Safe, Healthy, and Drug Free Communities Learning Objectives Discover how the pillars approach utilizes
More informationPart of the Continuum of Care. Harm Reduction. Gino Vumbaca President Harm Reduction Australia
Part of the Continuum of Care Harm Reduction Gino Vumbaca President Harm Reduction Australia What is Harm Reduction The defining features are the focus on the reduction of harm, rather than on the prevention
More informationPart 1: Introduction & Overview
Part 1: Introduction & Overview We envision a collaborative, participative partnership around IDU that: Provides all relevant and interested stakeholders with a voice and role. Promotes awareness of the
More informationHow can we/should we study purported changes in drug market supply?
How can we/should we study purported changes in drug market supply? Dr Caitlin Hughes and Dr Jenny Chalmers 6 th International Study for the Society of Drug Policy Conference 30 May 2012, Canterbury DPMP
More informationMoving Beyond the War on Drugs
James A. Baker III Institute for Public Policy Rice University Moving Beyond the War on Drugs The Swiss Drug Policy Francois van der Linde Chairman of the Swiss Federal Commission for Drug Issues PRESENTED
More informationAssessment Schedule 2015 Health: Demonstrate understanding of issues to make health-enhancing decisions in drug-related situations (90975)
NCEA Level 1 Health (90975) 2015 page 1 of 6 Assessment Schedule 2015 Health: Demonstrate understanding of issues to make health-enhancing decisions in drug-related situations (90975) Evidence Achievement
More informationHIV/AIDS Prevention, Treatment and Care among Injecting Drug Users and in Prisons
HIV/AIDS Prevention, Treatment and Care among Injecting Drug Users and in Prisons Ministerial Meeting on Urgent response to the HIV/AIDS epidemics in the Commonwealth of Independent States Moscow, 31 March
More informationPROBLEMATIC USE OF (ILLEGAL) DRUGS
PROBLEMATIC USE OF (ILLEGAL) DRUGS A STUDY OF THE OPERATIONALISATION OF THE CONCEPT IN A LEGAL CONTEXT SUMMARY 1. Introduction The notion of problematic drug use has been adopted in Belgian legislation
More informationGLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA. The critical need to scale up opioid substitution therapy
GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA The critical need to scale up opioid substitution therapy Craig McClure IAS Executive Director Outline of Presentation 1.
More informationTHE ECONOMICS OF TOBACCO AND TOBACCO CONTROL, A DEVELOPMENT ISSUE. ANNETTE DIXON, WORLD BANK DIRECTOR, HUMAN DEVELOPMENT SECTOR
THE ECONOMICS OF TOBACCO AND TOBACCO CONTROL, A DEVELOPMENT ISSUE. ANNETTE DIXON, WORLD BANK DIRECTOR, HUMAN DEVELOPMENT SECTOR EUROPE AND CENTRAL ASIA REGION The facts and figures clearly show the enormous
More informationYoung but not so restless: Trends in the age-specific rate of offending
NSW Bureau of Crime Statistics and Research Bureau Brief Young but not so restless: Trends in the age-specific rate of offending Don Weatherburn, Karen Freeman and Jessie Holmes Issue paper no. 98 September
More information9. In comparing the relative toxicity of marijuana and cocaine, it is important to take into account A. the user's gender. B. availability and price.
02 Student: 1. The Canadian government, in the early 1900s had virtually no laws regulating the sale and use of drugs. In general the government took a "hands-off" approach that has been referred to as
More informationRunning Head: LEGALIZATION OF MARIJUANA 1 LEGALIZATION OF RECREATIONAL MARIJUANA IN CALIFORNIA
Running Head: LEGALIZATION OF MARIJUANA 1 LEGALIZATION OF RECREATIONAL MARIJUANA IN CALIFORNIA By Name Course Tutor s Name Institution Date LEGALIZATION OF MARIJUANA 2 Legalization of Recreational Marijuana
More informationJSNA Substance Misuse
JSNA Substance Misuse Introduction 9.1. Substance misuse causes less damage to health in absolute population terms than tobacco or alcohol. However, its association with crime and antisocial behaviour
More informationRapporteur report of Session 2: New Trends in TDI clients. Thursday, September 20th 2012, ( Room 106) Chair: Dragica Katalinic
Rapporteur report of Session 2: New Trends in TDI clients Thursday, September 20th 2012, (14.30 16.00 Room 106) Chair: Dragica Katalinic Rapporteur: Christine Marchand-Agius 1. Presentation on new trends
More informationDrinking, Drugs and Smoking
Drinking, Drugs and Smoking About This Document http://oeapng.info While not all young people smoke, drink regularly or misuse drugs, some do; and, if they do, this could manifest itself on an off-site
More informationStrategies for Federal Agencies
Confronting Pain Management and the Opioid Epidemic Strategies for Federal Agencies Over the past 25 years, the United States has experienced a dramatic increase in deaths from opioid overdose, opioid
More informationMarijuana in Washington. Arrests, Usage, and Related Data
Arrests, Usage, and Related Data Jon Gettman, Ph.D. The Bulletin of Cannabis Reform www.drugscience.org 10/19/2009 1 Introduction This state report is part of a comprehensive presentation of national,
More informationInformal meeting of the Justice and Home Affairs Ministers Sopot July 2011
Informal meeting of the Justice and Home Affairs Ministers Sopot 18-19 July 2011 New challenges to EU anti-drug policy. I. Introduction Every hour an EU citizen dies of a drug overdose. There are as many
More informationThe War on Drugs: the Hub of Most American Crises
LEAP.CC Law Enforcement Against Prohibition The War on Drugs: the Hub of Most American Crises by James E. Gierach Northwestern University SSDP, NORML Thursday, April 23, 2009 Preface Nothing herein is
More informationAN OPTIMAL REGULATORY MIX FOR METHAMPHETAMINE PRECURSORS?
AN OPTIMAL REGULATORY MIX FOR METHAMPHETAMINE PRECURSORS? Janet Ransley Griffith University Responding to methamphetamine problems How should governments respond to the problem of domestic, illicit production
More informationIdentifying Common Ground on Public Health for UNGASS 2016:
Identifying Common Ground on Public Health for UNGASS 2016: What does a public health approach to global drug policy mean in practice? 21 April 2015, United Nations Headquarters Concept Note As momentum
More informationDRUG DIVERSION STUDY TOUR ANNIE MADDEN EXECUTIVE OFFICER AUSTRALIAN INJECTING AND ILLICIT DRUG USERS LEAGUE (AIVL)
DRUG DIVERSION STUDY TOUR ANNIE MADDEN EXECUTIVE OFFICER AUSTRALIAN INJECTING AND ILLICIT DRUG USERS LEAGUE (AIVL) Overview Who is AIVL? Drug User Networks globally Nothing about us without us why is MIPUD
More informationAddressing Drug Addiction in Australia
The ICE Epidemic: Addressing Drug Addiction in Australia A White Paper 24 August 2015 Rev. Angel Roldán Life-Gate Inc. PO Box 11097 Frankston VIC 3199 Australia www.life-gate.org Contents 1. Introduction
More informationHOW TO ARTICULATE THE PROBLEM Conducting a Situational Analysis for a Drug Abuse Prevention Programme P R O C C E R
HOW TO ARTICULATE THE PROBLEM Conducting a Situational Analysis for a Drug Abuse Prevention Programme Do We Really Know What We Know Do you have a drug problem in your community? # of Users # of Related
More informationINTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D
INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D Secretariat for Multidimensional Security FIFTY-FIFTH REGULAR SESSION April 29 - May 1, 2014 Washington, D.C. OEA/Ser.L/XIV.2.55 CICAD/doc.2097/14
More informationand practice: Three AIC examples Dr Adam Tomison
The impact of research on policy and practice: Three AIC examples Dr Adam Tomison Director 1. Labour trafficking (non-sexual forced labour or slavery) Only 2 prosecuted cases of labour trafficking in Australia
More informationMarijuana in Washington, DC. Arrests, Usage, and Related Data
Marijuana in Washington, DC Arrests, Usage, and Related Data Jon Gettman, Ph.D. The Bulletin of Cannabis Reform www.drugscience.org November 5, 2009 1 Introduction This state report is part of a comprehensive
More informationStrategies to Reduce Harm and HIV/AIDS Infection among Drug Using Populations
cessation of use may be the most effective form of harm reduction but, in reality, many clients do not wish to cease using, or find it too difficult. (Addy & Ritter, 2000, p.1) Introduction Historically,
More information22 April 2002 Central Australian Aboriginal Congress Submission: Taskforce on Illicit Drugs
22 April 2002 Central Australian Aboriginal Congress Submission: Taskforce on Illicit Drugs Congress accepts the following definition: DRUG: a substance that produces a psychoactive effect. Includes alcohol,
More information[Name of Author] [Institutional Affiliation] [Date of Submission]
PROS AND CONS OF LEGALIZING LIGHT DRUGS [Name of Author] [Institutional Affiliation] [Date of Submission] 1 In many states, a number of drugs have been banned because they are considered to have harmful
More informationTHE DEMAND FOR METHADONE MAINTENANCE TREATMENT IN AUSTRALIA
THE DEMAND FOR METHADONE MAINTENANCE TREATMENT IN AUSTRALIA Wayne Hall Technical Report N o. 28 The Demand for Methadone Maintenance Treatment in Australia Wayne Hall Director National Drug and Alcohol
More informationOur dilemma is that we hate change and love it at the same time; what we really want is for things to remain the same but get better.
Our dilemma is that we hate change and love it at the same time; what we really want is for things to remain the same but get better. Sydney J. Harris A common but not so constructive response to pressing
More informationLegalization of Cannabis: The Way Forward
Percent 2018/05/03 Legalization of Cannabis: The Way Forward W. O. McCormick Academic Day Hon. A. Anne McLellan, PC, OC, AOE Friday, April 27 2018 Current Context 40 Past year cannabis use, by age group,
More informationSupporting the Establishment of Prison- based Harm Reduction Policies and Programs in Eastern Europe and the Former Soviet Union
Supporting the Establishment of Prison- based Harm Reduction Policies and Programs in Eastern Europe and the Former Soviet Union Thomas Kerr 1, Matt Curtis 2, Ralf Jürgens 1 1 Canadian HIV/AIDS Legal Network
More informationPolicy Options for the Regulation of Electronic Cigarettes
Policy Options for the Regulation of Electronic Cigarettes Consultation submission Your details This submission was completed by: Address: (name) Mark Forsyth (street/box number) 3 Queens Wharf (town/city)
More informationChanges in indicators of methamphetamine use and. property crime rates in Oregon
Changes in indicators of methamphetamine use and property crime rates in Oregon Meredith L. Bliss, Research Analyst, Oregon Criminal Justice Commission Salem, Oregon 17 February 2004 Nothing in this report
More informationSubstance use and misuse
An open learning programme for pharmacists and pharmacy technicians Substance use and misuse Educational solutions for the NHS pharmacy workforce DLP 160 Contents iii About CPPE open learning programmes
More informationModels of good practice in drug treatment in Europe. Project group
Models of good practice in drug treatment in Europe ( moretreat 2006329 ) Project group Hamburg, London, Rome, Stockholm, Vienna, Warsaw, Zurich Project duration: 17 months from April 2006 August 2008
More informationSeptember Contact John Rogerson Chief Executive Officer Alcohol and Drug Foundation Executive Summary adf.org.
AN EXECUTIVE SUMMARY OF EVIDENCE PUT TO THE INQUIRY INTO THE DRUGS, POISONS AND CONTROLLED SUBSTANCES AMENDMENT (PILOT MEDICALLY SUPERVISED INJECTING CENTRE BILL) 2017 September 2017 Contact John Rogerson
More informationDrug and Alcohol Awareness
Northern Territory Police Drug and Alcohol Awareness St Philips College, 7 th September 2016 Presented by: Danny Bell, Youth and Community Engagement Alice Springs Police www.police.nt.gov.au 1 Overview
More informationMethadone Diversion: Why it happens, what the illicit market looks like and the implications
Methadone Diversion: Why it happens, what the illicit market looks like and the implications Paul Duffy & Helen Baldwin Centre for Public Health Liverpool John Moores University Methadone provision and
More informationMarijuana in Louisiana. Arrests, Usage, and Related Data
Arrests, Usage, and Related Data Jon Gettman, Ph.D. The Bulletin of Cannabis Reform www.drugscience.org 10/19/2009 1 Introduction This state report is part of a comprehensive presentation of national,
More informationAre current social marketing campaigns getting through to undergraduate university students?
University of Wollongong Research Online Faculty of Health and Behavioural Sciences - Papers (Archive) Faculty of Science, Medicine and Health 2003 Are current social marketing campaigns getting through
More informationWorking to Reform Marijuana Laws
MARIJUANA DECRIMINALIZATION TALKING POINTS TALKING POINT #1: Decriminalizing marijuana frees up police resources to deal with more serious crimes. Working to Reform Marijuana Laws 60,000 individuals are
More informationCriminal Justice (Psychoactive Substances) Bill Regulatory Impact Analysis
Criminal Justice (Psychoactive Substances) Bill 2010 Regulatory Impact Analysis 1. Summary RIA Summary of Regulatory Impact Analysis (RIA) Department/Office: Department of Justice and Law Reform Stage:
More informationCOMMISSION IMPLEMENTING DECISION. of
EUROPEAN COMMISSION Brussels, 26.7.2016 C(2016) 4592 final COMMISSION IMPLEMENTING DECISION of 26.7.2016 concerning national provisions notified by Finland prohibiting the placing on the market of certain
More informationPublic consultation for the 2016 evaluation of the EU Drugs Strategy and Action Plan on Drugs
Case Id: d79bf7da-998d-4fa4-b202-bac606c39a58 Date: 29/04/2016 09:21:26 Public consultation for the 2016 evaluation of the EU Drugs Strategy and Action Plan on Drugs Fields marked with are mandatory. Please
More informationPublic Provision of Heroin for Addicts 197 Background: The Swiss Trials
196 Harry Clarke The basis for abstinence objectives is not straightforward to elicit since health and other risks associated with heroin use have not been clearly spelt out. Some long-term addicts have
More informationORGANIZATION OF AMERICAN STATES
ORGANIZATION OF AMERICAN STATES INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION FIRST INTER-REGIONAL FORUM OF EU-LAC CITIES: PUBLIC POLICIES IN DRUG TREATMENT April 2 5, 2008 Santo Domingo, Dominican Republic
More informationLegalization, Regulation and Restriction of Access to Cannabis
Legalization, Regulation and Restriction of Access to Cannabis Presentation to UNSM May 26th, 2017 Departments of Justice, Health and Wellness and Finance and Treasury Board Today Origin and Federal Context
More informationALCOHOL & SUBSTANCE MISUSE POLICY
ALCOHOL & SUBSTANCE MISUSE POLICY Introduction Rutledge has a zero tolerance approach to drug, alcohol and substance misuse. We wish to: Enable staff to recognise drug, alcohol and substance misuse problems,
More informationPsychoactive Substances (Increasing Penalty for Supply and Distribution) Amendment Bill
Psychoactive Substances (Increasing Penalty for Supply and Distribution) Amendment Bill 16 1 Report of the Justice Committee September 2018 Contents Recommendation... 2 About the bill as introduced...
More informationCOUNCIL OF THE EUROPEAN UNION. Brussels, 7 July /04 CORDROGUE 59
COUNCIL OF THE EUROPEAN UNION Brussels, 7 July 2004 11267/04 CORDROGUE 59 I/A ITEM NOTE from : General Secretariat to : COREPER/Council Subject : Draft Council Resolution on Cannabis 1. At its meeting
More informationMarijuana in Georgia. Arrests, Usage, and Related Data
Arrests, Usage, and Related Data Jon Gettman, Ph.D. The Bulletin of Cannabis Reform www.drugscience.org 10/19/2009 1 Introduction This state report is part of a comprehensive presentation of national,
More informationCannabis Legalization in Alberta
Cannabis Legalization in Alberta Managing Access and Public Health Roundtable #3 Discussion Topics Limits on how much cannabis adults and minors can possess in public Limits for growing cannabis at home
More informationINQUIRY INTO USE OF CANNABIS FOR MEDICAL
Submission No 58 INQUIRY INTO USE OF CANNABIS FOR MEDICAL PURPOSES Organisation: NSW Council for Civil Liberties Date received: 15/02/2013 The NSW Council for Civil Liberties considers that drug use should
More informationQUESTIONNAIRE. Submission Information. Information for follow-up purposes. Head of International Drug Policy, Home Office
IMPLEMENTATION OF THE RECOMMENDATIONS ADOPTED BY THE TWENTY-SIXTH SESSION OF HONLEA, LATIN AMERICA AND THE CARIBBEAN, SANTIAGO, CHILE 3-7 OCTOBER 2016 QUESTIONNAIRE Submission Information Name of country:
More informationPlain Packaging of Tobacco Products FAQ
Plain Packaging of Tobacco Products FAQ Key Public Messages 1. Plain packaging is an evidence based measure that can save lives and protect public health by: 1. reducing the attractiveness of tobacco products;
More informationChad Sabora, BS, MS, JD Missouri Network for Opiate Reform and Recovery. Drug Policy, Harm Reduction, and What s Next
Chad Sabora, BS, MS, JD Missouri Network for Opiate Reform and Recovery Drug Policy, Harm Reduction, and What s Next The start or lack thereof of Drug Policy in the United States The Harrison Narcotics
More informationStudent Drug Policy Approved GE March 2011 Updated May 2012 and approved GE November 2012 Next Review November 2018 Page 1
Name of policy: Created: March 2011 Updated: May 2012 Approved by Governing Executive: March 2011 Last reviewed: November 2015 Responsibility for review: H&S and Governing Executive Date of next review:
More informationHRS Group UK Drug and Alcohol Policy
HRS Group UK Drug and Alcohol Policy 1.0 Introduction The HRS Group UK Policy on Alcohol and Drugs is a fundamental part of the Company s strategy to safeguard the health, safety and welfare of all its
More informationDrug Incidents & Prevention (Smoking and Substance Misuse) Policy
Drug Incidents & Prevention (Smoking and Substance Misuse) Policy Review Period: Annually Date Policy Last Reviewed: January 2018 Date of Governor Approval: January 2018 Date for Review: January 2019 The
More informationPublic consultation for the 2016 evaluation of the EU Drugs Strategy and Action Plan on Drugs
Case Id: a79a0e63-798e-4bb8-9bac-4d373def86d2 Date: 07/03/2016 12:50:57 Public consultation for the 2016 evaluation of the EU Drugs Strategy and Action Plan on Drugs Fields marked with are mandatory. Please
More informationEuropean Legal Database on Drugs
European Legal Database on Drugs / Reviewing legal aspects of substitution treatment at international level Prepared by the EMCDDA at the request of the Pompidou Group Secretariat EMCDDA ELDD Comparative
More informationUnderstanding how a high-level drug trafficking network in Australia adapts to changes in its drug supply
Understanding how a high-level drug trafficking network in Australia adapts to changes in its drug supply Matthew O Reilly, Caitlin Hughes, & Alison Ritter. 2018 NDARC Symposium. Introduction Most illicit
More informationPublic Health Association of British Columbia
October 30 th, 2017 Open Letter to the Government of British Columbia: BC Needs an OPIOID ACTION PLAN Since April, 2016 when the epidemic of opioid overdose deaths was declared a Public Health Emergency
More informationNational Framework for Ethical Behaviour and Integrity in Basketball Appendix 3. Illicit Drugs Policy. Date adopted by BA Board 3 April 2017
National Framework for Ethical Behaviour and Integrity in Basketball Appendix 3 Illicit Drugs Policy Date adopted by BA Board 3 April 2017 Date Effective 1 July 2017 Table of Contents 1. Introduction...
More informationVictorian Parliamentary Inquiry into the Drugs, Poisons and Controlled Substances Amendment (Pilot Medically Supervised Injecting Centre) Bill 2017
Victorian Parliamentary Inquiry into the Drugs, Poisons and Controlled Substances Amendment (Pilot Medically Supervised Injecting Centre) Bill 2017 19 April 2017 That the Government: VHA Recommendations
More informationHIV AND PEOPLE WHO INJECT DRUGS
UNAIDS 2017 HIV AND PEOPLE WHO INJECT DRUGS People who use and inject drugs are among the groups at highest risk of exposure to HIV, but remain marginalized and out of reach of health and social services.
More informationAn Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis. February 2018
An Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis February 2018 I m here today to provide 1 2 3 Context for the Government of Canada s plan to legalize,
More informationPrescription for Progress Study conducted by the Siena College Research Institute April 10 - May 4, Stakeholders - MOE +/- 4.
How serious a public health problem in the State of New York is each of the following: [Q1A-Q1I ROTATED] Q1A. Alcohol abuse Very serious 61% 63% 53% 63% 36% 71% 52% Somewhat serious 35% 35% 38% 33% 52%
More informationFAQ: Alcohol and Drug Treatments
Question 1: Are DUI offenders the most prevalent of those who are under the influence of alcohol? Answer 1: Those charged with driving under the influence do comprise a significant portion of those offenders
More informationPublic consultation for the 2016 evaluation of the EU Drugs Strategy and Action Plan on Drugs
Case Id: 72f3c8af-e4e6-438f-87c8-fea4174490b8 Date: 27/05/2016 10:40:37 Public consultation for the 2016 evaluation of the EU Drugs Strategy and Action Plan on Drugs Fields marked with are mandatory. Please
More informationModule 6: Substance Use
Module 6: Substance Use Part 1: Overview of Substance Abuse I am Martha Romney and I am presenting on substance abuse. This module focuses on the healthy people 2020 objective to reduce substance abuse
More information